PTC Therapeutics to Participate at Upcoming Investor Conference
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced its participation in the SVB Securities Global Biopharma Conference on February 14, 2023, at 9:20 a.m. EST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced its participation in the SVB Securities Global Biopharma Conference on February 14, 2023, at 9:20 a.m. EST. The company will present a comprehensive overview of its operations and strategic focus. A live webcast of the presentation will be available on PTC's Events and Presentations page and will be archived for 30 days. PTC is dedicated to developing innovative treatments for patients with rare disorders, aiming to maximize access to transformative medicines. For further details, visit www.ptcbio.com.
Details
News Market Reaction – PTCT
The recorded move for PTCT in the trading session of this news was +1.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The presentation will be webcast live on the Events and Presentations page under the Investor section of
About
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.
For More Information:
Investors:
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conference-301737826.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.